Healthcare entity
market-trends is the sole category represented across all 1 tracked stories. COSMOS Trial is most often covered alongside Brigham and Women's Hospital, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 4.1 for the same window.
Last mentioned: Mar 9, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
market-trends is the sole category represented across all 1 tracked stories. COSMOS Trial is most often covered alongside Brigham and Women's Hospital, which appears in 1 of these 1 story. They are less corroborated than the beat average, carrying 2 original sources each against 4.1 for the same window. Their average consequence score of 6 sits level with the 6 recorded across the beat in that window. We currently track 1 Healthcare story that mention COSMOS Trial, all published on March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering COSMOS Trial. Shared-story counts are live from our verified record — not editorial picks.
Biological Aging Analysis
New data confirms daily supplements slow the ticking of the biological aging clock in older adults.
COSMOS-Web Study
Research published in the American Journal of Clinical Nutrition linked multivitamins to improved memory.
Initial COSMOS Results
Early data focused on cardiovascular and cancer outcomes showed neutral results for multivitamins.
A prespecified analysis of the COSMOS trial reveals that daily multivitamin-multimineral supplements significantly slow markers of biological aging in older adults. The findings provide clinical weight to the use of common supplements as a low-cost intervention for extending biological healthspan.
Source: MedPage Today · miragenews.com
COSMOS Trial is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
